Cheyne Capital Management (UK)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Cheyne Capital Management (UK)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,443	Closed	-$327K	–	64
2022 Q4	$327K	Buy	+26,443	New	+$374K	0.57%	46
2015 Q4	–	Sell	-10,150	Closed	-$1.68M	–	45
2015 Q3	$1.68M	Sell	10,150 -14,593	-59%	-$3.21M	0.79%	19
2015 Q2	$5.98M	Sell	24,743 -24,394	-50%	-$6.5M	1.93%	9
2015 Q1	$13.9M	Buy	49,137 +10,405	+27%	+$2.25M	3.34%	10
2014 Q4	$6.04M	Buy	38,732 +28,856	+292%	+$5.33M	1.59%	12
2014 Q3	$2.34M	Buy	+9,876	New	+$2.52M	0.83%	18

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Cheyne Capital Management (UK)'s ICPT Position: Q1 2023 in Review

Cheyne Capital Management (UK) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 26,443 shares — an estimated $327K sold.

Cheyne Capital Management (UK) first reported a position in ICPT in Q3 2014 and held it in 6 quarters. The position peaked at $13.9M in Q1 2015. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

Cheyne Capital Management (UK) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Cheyne Capital Management (UK) sold 26,443 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $327K.
Cheyne Capital Management (UK) first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 6 quarters.
Cheyne Capital Management (UK)'s Intercept Pharmaceuticals, Inc. position peaked at $13.9M in Q1 2015.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.